Cargando…
Alternative redox forms of ASNA-1 separate insulin signaling from tail-anchored protein targeting and cisplatin resistance in C. elegans
Cisplatin is a frontline cancer therapeutic, but intrinsic or acquired resistance is common. We previously showed that cisplatin sensitivity can be achieved by inactivation of ASNA-1/TRC40 in mammalian cancer cells and in Caenorhabditis elegans. ASNA-1 has two more conserved functions: in promoting...
Autores principales: | Raj, Dorota, Billing, Ola, Podraza-Farhanieh, Agnieszka, Kraish, Bashar, Hemmingsson, Oskar, Kao, Gautam, Naredi, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060345/ https://www.ncbi.nlm.nih.gov/pubmed/33883621 http://dx.doi.org/10.1038/s41598-021-88085-y |
Ejemplares similares
-
Cisplatin toxicity is counteracted by the activation of the p38/ATF-7 signaling pathway in post-mitotic C. elegans
por: Raj, Dorota, et al.
Publicado: (2023) -
A proinsulin-dependent interaction between ENPL-1 and ASNA-1 in neurons is required to maintain insulin secretion in C. elegans
por: Podraza-Farhanieh, Agnieszka, et al.
Publicado: (2023) -
Identification of C. elegans ASNA-1 domains and tissue requirements that differentially influence platinum sensitivity and growth control
por: Raj, Dorota, et al.
Publicado: (2022) -
Depletion of the ER chaperone ENPL-1 sensitizes C. elegans to the anticancer drug cisplatin
por: Natarajan, Balasubramanian, et al.
Publicado: (2013) -
Mitochondrial Function Is Required for Secretion of DAF-28/Insulin in C. elegans
por: Billing, Ola, et al.
Publicado: (2011)